Home / Clinical Trials / Closed Trials

Closed Trials

TYPE

Bladder

STATUS

Closed

LOCATION

PROTOCOL #

ANZUP 1401

BL12

A multicentre randomised phase II trial comparing Nab-paclitaxel to Paclitaxel in patients with advanced urothelial cancer progressing on or after a platinum containing regimen

TYPE

Prostate

STATUS

Closed

LOCATION

NSW | VIC | QLD

PROTOCOL #

ANZUP 2002

DIPPER

A multi-centre, randomised phase 2 clinical trial of early salvage radiotherapy versus surveillance for biochemical recurrence after radical prostatec…

TYPE

Kidney

STATUS

Closed

LOCATION

PROTOCOL #

ANZUP 0901

EVERSUN

A phase 2 trial evaluating the effect of Everolimus alternating with Sunitinib on progression-free survival in patients with advanced renal cell carcinoma.

TYPE

Prostate

STATUS

Closed

LOCATION

NSW | VIC

PROTOCOL #

ANZUP 1903

GUIDE

A phase II trial of biomarker-driven intermittent docetaxel in metastatic castration-resistant prostate cancer (mCRPC)

TYPE

Kidney

STATUS

Closed

LOCATION

NSW | VIC | QLD | SA | WA

PROTOCOL #

ANZUP 1601

KEYPAD

Denosumab and Pembrolizumab in clear cell renal carcinoma: a phase II trial

TYPE

Prostate

STATUS

Closed

LOCATION

PROTOCOL #

ANZUP 1501

Pain-Free TRUS B

A phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasound-guided prostate biopsy

TYPE

Bladder

STATUS

Closed

LOCATION

NSW | VIC | WA

PROTOCOL #

ANZUP 1502

PCR-MIB

Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
Study testing whether adding immunotherapy (pembrolizumab) to chemotherapy and radiation improves outcomes for people with bladder cancer that has gro…

TYPE

Prostate

STATUS

Closed

LOCATION

NSW | VIC | QLD | SA | WA

PROTOCOL #

ANZUP 1603

TheraP

A randomised phase II trial of 177Lu-PSMA617 theranostic versus cabazitaxel in progressive metastatic castration resistant prostate cancer
Study testing whether a targeted radiation treatment (LuPSMA) works better and has fewer side effects than chemotherapy for people with advanced, trea…

TYPE

Kidney

STATUS

Closed

LOCATION

NSW | VIC | QLD | SA

PROTOCOL #

ANZUP 1802

UNICAB

A Phase II Trial Of Single Agent Cabozantinib In Patients With Locally Advanced Or Metastatic Non-Clear Cell Renal Cell Carcinoma Post Immunotherapy Or Who Are Unsuitable For Immunotherapy
Study testing whether a targeted cancer treatment (cabozantinib) is safe and effective for people with less common types of advanced kidney cancer (non-clear cell kidney cancer).

TYPE

Kidney

STATUS

Closed

LOCATION

NSW | VIC | QLD | SA | WA

PROTOCOL #

ANZUP 1602

UNISoN

UNISoN: anzUp Nivo -> Ipi + Nivo Sequential Non-clear cell Proposed phase II sequential cohort trial of single agent Nivolumab, then combination Ipil…
Study testing whether immunotherapy (nivolumab with or without ipilimumab) can improve outcomes for people with less common types of advanced kidney cancer (non-clear cell kidney cancer).

TYPE

Testicular

STATUS

Closed

LOCATION

PROTOCOL #

Version 2, 19/12/16

e-TC 2.0

e-TC 2.0 Further development and pilot testing of an online psychological intervention aimed at reducing anxiety, depression and fear of cancer recurrence in testicular cancer survivors

TYPE

Bladder

STATUS

Closed

LOCATION

NSW | VIC | QLD | WA | NZ | UK | Canada | USA

PROTOCOL #

N/A

NMIBC-SI Evaluation

Developing a Patient-Reported Symptom Index for Non-muscle Invasive Bladder Cancer